Internal Medicine, Gastroenterology · Charlotte, NC
NPI
1528086980
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
10620 Park Rd Ste 102
Charlotte, NC, 28210
Phone (704) 543-7305
Groups this clinician bills Medicare through
Medicare paid, 2024
$265K
4,078 services
Medicare patients, 2024
783
Average age 74
Drug cost, 2024
$2.8M
2,419 prescriptions
Company payments, 2025
$8,673
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronnie Cyzner was code 99439 (chronic, principal, and transitional care management), 1,475 times for 138 patients. In total Ronnie Cyzner billed 4,078 services in 40 codes, and Medicare paid $265K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,475 | 138 | $37.74 | $56K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 841 | 139 | $48.74 | $41K |
| 99213 Office E&M - Established | Office | 397 | 271 | $66.74 | $26K |
| 99214 Office E&M - Established | Office | 225 | 184 | $93.07 | $21K |
| 43239 Upper GI Endoscopy | Facility | 145 | 142 | $72.02 | $10K |
| 45385 Colonoscopy - Lesion Removal | Facility | 136 | 134 | $209.00 | $28K |
| 99457 E&M - Miscellaneous | Office | 119 | 21 | $38.98 | $4,639 |
| 99204 Office E&M - New | Office | 109 | 109 | $119.99 | $13K |
| 99454 E&M - Miscellaneous | Office | 79 | 19 | $36.50 | $2,884 |
| 45380 Lower GI Endoscopy - Other | Facility | 62 | 61 | $111.38 | $6,906 |
| 99221 Hospital E&M - Initial | Facility | 61 | 60 | $66.38 | $4,049 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 60 | 57 | $163.56 | $9,814 |
| 99222 Hospital E&M - Initial | Facility | 60 | 58 | $104.64 | $6,278 |
| 99203 Office E&M - New | Office | 51 | 51 | $76.50 | $3,902 |
| 99231 Hospital E&M - Subsequent | Facility | 38 | 33 | $38.76 | $1,473 |
By year: 2022 $252K for 3,906 services; 2023 $259K for 4,250 services; 2024 $265K for 4,078 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ronnie Cyzner prescribed most often to Medicare patients was Omeprazole, with 381 prescriptions and refills. In total Ronnie Cyzner wrote 2,419 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 381 | 846 | 135 | $3,889 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 198 | 198 | 194 | $13K |
| Linzess Linaclotide | 151 | 269 | 52 | $141K |
| Creon Lipase/Protease/Amylase | 114 | 139 | 27 | $320K |
| Lubiprostone Generic | 108 | 170 | 46 | $15K |
| Pantoprazole Sodium Generic | 91 | 222 | 36 | $1,219 |
| Amitriptyline Hcl Generic | 88 | 146 | 28 | $853 |
| Ibsrela Tenapanor Hcl | 69 | 92 | 18 | $157K |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 67 | 67 | 65 | $11K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 66 | 66 | 60 | $1,047 |
| Famotidine Generic | 66 | 106 | 23 | $901 |
| Dicyclomine Hcl Generic | 65 | 92 | 28 | $765 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 58 | 58 | 57 | $8,394 |
| Stelara Ustekinumab | 56 | 84 | Under 11 | $1.5M |
| Mesalamine Generic | 51 | 78 | Under 11 | $7,506 |
Brand drugs: - claims; generic drugs: 1,484 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronnie Cyzner $8,673 ($8,673 in general payments such as food, travel and fees) from 32 companies. The largest payer was Abbvie Inc. with $2,011.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 97 | $2,011 |
| Janssen Biotech, Inc. JNJ | 40 | $911 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 54 | $699 |
| Madrigal Pharmaceuticals MDGL | 13 | $525 |
| QOL Medical, LLC | 20 | $449 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 23 | $431 |
| Ardelyx, Inc. ARDX | 18 | $370 |
| Lilly USA, LLC LLY | 20 | $347 |
| Aimmune Therapeutics, Inc. | 14 | $343 |
| Pfizer Inc. PFE | 18 | $320 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.